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Abstract
Purpose Patients aged > 80 years represent an increasing proportion of colon cancer diagnoses. Selecting patients for elective surgery
is challenging because of possibly compromised health status and functional decline. The aim of this retrospective, population-based
study was to identify risk factors and health measures that predict short-term mortality after elective colon cancer surgery in the aged.
Methods All patients > 80 years operated electively for stages I–III colon cancer from 2005 to 2016 in four Finnish hospitals
were included. The prospectively collected data included comorbidities, functional status, postoperative surgical and medical
outcomes as well as mortality data.
Results A total of 386 patients (mean 84.0 years, range 80–96, 56% female) were included. Male gender (46% vs 35%, p = 0.03),
higher BMI (51% vs 37%, p = 0.02), diabetes mellitus (51% vs 37%, p = 0.02), coronary artery disease (52% vs 36%, p = 0.003)
and rheumatic diseases (67% vs 39%, p = 0.03) were related to higher risk of complications. The severe complications were more
common in patients with increased preoperative hospitalizations (31% vs 15%, p = 0.05) and who lived in nursing homes (30%
vs 17%, p = 0.05). The 30-day and 1-year mortality rates were 6.0% and 15% for all the patients compared with 30% and 45% in
patients with severe postoperative complications (p < 0.001). Severe postoperative complications were the only significant
patient-related variable affecting 1-year mortality (OR 9.60, 95% CI 2.33–39.55, p = 0.002).
Conclusions The ability to identify preoperatively patients at high risk of decreased survival and thus prevent severe postoper-
ative complications could improve overall outcome of aged colon cancer patients.
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Introduction
The incidence of colorectal cancer has tripled during the past
five decades, and the risk of having colorectal cancer increases
with age [1]. According to the Finnish Cancer Registry data
from 2016, 27% of all colorectal patients were aged 80 years
or more [1]. The number of aged people diagnosed with co-
lorectal cancer will increase as the population ages [2].
If possible, colon cancer is managed by radical surgical
resection [3, 4]. Previous studies show comparable disease-
specific survival rates for all age groups, which advocates
tumour resection with curative purpose [5, 6]. In the
EUROCARE-5 study, 5-year overall survival rate was 49%
for colon cancer patients of 75 years or older while overall
survival rate for all ages was 57% in Europe [7].
Corresponding numbers from 2016 in Finland were 60% for
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patients of 75 years and 66% for all ages [1]. In the oldest
patients, however, the survival benefit of operative treatment
(compared with other treatments) is only apparent after the
first two postoperative years due to the risks of surgery [8–10].
Increased age, physical and cognitive disabilities, and pre-
vious hospitalizations may predispose to postoperative mor-
bidity and mortality [11]. Colorectal cancer surgery is consid-
ered high risk, with reported postoperative major complication
and 30-day mortality rates of 16–24% and 1–6%, respectively
[12, 13]. Operative treatment of colorectal cancer in the aged
is associated with higher morbidity (35–45%) and mortality
rates both in the immediate postoperative period and during
the first year after surgery (6–16% in 30 days, 14–37% at
1 year) [12–17]. Compared with younger people, the 30-day
mortality in the group of aged patients underestimates 1-year
mortality due to prolonged impact of the perioperative period
[8, 18]. However, a recent Dutch study shows better postop-
erative outcome with almost equal 1-year survival rates for
older and younger colorectal patients, supporting tailor-made
decisions on surgical treatments for older patients [19].
It is important to have relevant and reliable data concerning
older aged colorectal cancer patient’s surgery and postopera-
tive morbidity and survival numbers. Surgeons and oncolo-
gists treating patients with colon cancer should become aware
of that 43% of their patients are > 75 years and that many of
these older patients are frail with comorbidities which demand
careful patient assessment [20]. Proper patient selection and
careful consideration of appropriate surgical candidates in-
cluding preoperative optimization of medical comorbidities,
nutritional status and physical performance enables colorectal
cancer surgery to be performed with reduced morbidity and
mortality rates with improved survival [21, 22].
The aim of this study was to identify preoperative risk
factors and measures of overall health status affecting postop-
erative morbidity and mortality and their impact on 30-day
and 1-year survival in colon cancer patients aged 80 years
and older. In addition, the aim was to investigate time-trends
in postoperative short-term mortality and possible factors af-
fecting the outcome.
Material and methods
All patients aged 80 years and over who underwent an elective
resection for colon cancer during the period of 2005 and 2016
in four Finnish hospitals were retrospectively analyzed. The
catchment area of these hospitals ranged from 100,000 to
250,000 inhabitants (in total, approximately 750,000 inhabi-
tants). Exclusion criteria were metastatic or recurrent disease
and palliative or emergency surgery. Treatment of malignant
diseases is almost exclusively performed by public health care
system in Finland. We consider this study population-based
because patients are referred to certain hospital based on their
place of residence.
All the patients had histologically confirmed primary ade-
nocarcinoma of the colon, and preoperatively had colonosco-
py and computed tomography. They underwent radical sur-
gery for the primary tumour. Patients were evaluated for their
fitness for elective surgery with general anaesthesia but were
not preselected any other way. Decision to proceed with sur-
gery was based on patient’s general condition and comorbid-
ities. Prior geriatric evaluation was not routinely used.
For this study, cancer- and surgery-related data was collect-
ed from prospectively maintained, institutionally approved
and password-protected electronic colorectal databases in the
study hospitals and was supplemented by review of medical
records. Patients with colorectal cancer were identified using
ICD codes C18-C19 [23]. The collected clinical data included
patients´ characteristics, living status, hospitalizations in the
6 months before surgery, comorbidities, modified age-
adjusted Charlson Comorbidity Index [24] score (4–15; solid
tumour excluded with two points, all patients > 80 years
which contributes four points for all patients), other malignan-
cies, symptoms, operative procedures and postoperative re-
covery. Postoperative complications were defined and deter-
mined using the Clavien-Dindo classification [25], and severe
complications were graded into classes III–V. Tumours were
staged according to the Union for International Cancer
Control (UICC) TNM classification [26] and graded accord-
ing to the World Health Organization histological classifica-
tion system [27]. The number of lymph nodes was recorded in
every case. Patients with macroscopic or residual tumour were
excluded.
Postoperative surveillance was performed in out-patient
clinics according to the follow-up programs of the four hos-
pitals. Local recurrences and distant metastasis were identified
radiologically (ultrasound, computed tomography) or histo-
logically. The information was collected from the hospital
medical records and Statistics Finland for all patients with or
without arranged follow-up program.
The primary outcome measures were postoperative mor-
bidity (surgical and non-surgical complications) and mortality
30 days and 1 year after primary treatment. Mortality data
including causes of death were obtained from the
population-based statistics of Statistics Finland. Mortality
was assessed at 30 days and 1 year following surgery. The
follow-up duration data was calculated from the date of sur-
gery to the date of death or date of active follow-up in the
clinics (1 year after surgery).
The associations between categorical variables were tested
with the chi-square test or the Fisher exact test, when appro-
priate, and continuous variables with the Student’s t test.
Survival rates were calculated from the time of primary sur-
gery using the Kaplan-Meier method and were compared by
the log-rank test. A uni- and multivariable analysis of the
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factors which influenced 30-day and 1-year mortality was
carried out using binary logistic regression. All variables
(Table 4) that were statistically significant in the univariate
model were included in the multivariable model. Statistical
analyses were performed using SPSS version 23.
The study was approved by the ethics committee of
Pirkanmaa Hospital District, Tampere, Finland (R18188).
Results
A total of 386 patients were identified from the prospec-
tive records of the four hospitals. The mean age of the
study population was 84.1 years (range 80–96 years).
Most of the patients were female (56%), had an ASA III
classification (69%) and CCI score 4–5 (62%). Most of the
patients lived at home (90%), were not dependent on
others for daily help (56%) and had no hospital admission
in the previous 6 months (73%). Of the patients, 106
(28%) were operated in 2005–2008, 143 (37%) in 2009–
2012 and 137 (35%) in 2013–2016. Table 1 shows the
patients` baseline characteristics.
Most of the operative procedures were performed for
right-sided colon cancer (68%). An intended laparoscopic
resection was performed in 252 patients (65%) and in 35
cases (14%), the operation was converted to an open sur-
gery due to anatomical or technical reasons. One hundred
eighty-seven patients (50%) were discharged to other hos-
pitals or wards of healthcare centres. Readmission within
30 days of discharge occurred for 6.5% of the patients.
Postoperative adjuvant chemotherapy was given to 46%
(67/146) of stage III patients. Table 2 shows surgical char-
acteristics and outcomes.
Morbidity
Overall postoperative morbidity was 40% (154/386), with
24% (92/386) of patients having surgical complications.
The most common surgical complications were ileus
(7.0%), intra-abdominal or anastomotic bleeding (6.2%)
and anastomotic leakage (5.7%). The most common
non-surgical complications were cardiovascular (6.0%)
and pulmonary (4.7%). Both surgical and non-surgical
complications were recorded only for 1.8% (7/386) of
the patients. According to the Clavien-Dindo classifica-
tion, 18% (69/386) of patients had severe complications
(grades III–V), accounting for 45% (69/154) of all com-
plications. (Table 3).
Male gender (46% vs 35%, p = 0.03), diabetes mellitus
(51% vs 37%, p = 0.02), coronary artery disease (52% vs
36%, p = 0.003) and rheumatic diseases (67% vs 39%,
p = 0.03) were related to higher number of complications.
Patients with complications had higher BMI (26 vs 25,
p = 0.04). Operative approach (open or laparoscopic)
and operating time were not associated with increased rate
of complications.
More severe postoperative complications (Clavien-Dindo
III–V) were experienced by patients living in a nursing home
compared with those living in their own home (30% vs 17%,
p = 0.05), and by those who had hospital admissions during
the 6 months prior surgery compared with those who had none
(31% vs 15%, p = 0.05). Patients with severe complications
also had more intraoperative blood loss (median 50 ml vs
100 ml, p = 0.006).
Table 1 Patients’
baseline characteristics
(n = 386)
n / med % / (range)
Gender
Female 217 56.2
Male 169 43.8
Age, years 83.0 (80–96)
BMI, kg/m2 24.9 (15.4–40.6)
< 25 163 50.9
25–29.9 111 34.7
30- 46 14.4
Not available 66
Type of living
Home 336 90.1
Nursing home 37 9.9
Not known 13
Aid at home
No 152 55.9
Relatives 62 22.8
Other 58 21.3
Not known 114
Hospital admissions < 6 months
No 279 73.4
One 88 23.3
Two or more 13 3.3
ASA score
2 36 9.5
3 263 69.0
4 82 21.5
Not known 5
CCI score (4–15)
4 109 28.2
5 131 33.9
6 82 21.3
7–15 64 16.6
Operation year
2005–2008 106 27.5
2009–2012 143 37.0
2013–2016 137 35.5
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Mortality
The overall 30-day mortality was 6.0% (23/386). Six patients
died due to anastomotic leakage and three due to other surgical
complications (ileus, intraoperative haemorrhage and small
intestine perforation). Seven patients died due to cardiac com-
plications, three due to pulmonary problems and three due to
cerebral haemorrhage. One patient died of a ruptured abdom-
inal aneurysm 6 days after surgery.
The overall 1-year mortality was 15% (59/386). The most
important causes of death were cardiopulmonary (43%) and
surgery-related postoperative complications (17%). Cancer-
related mortality was 4.4%, accounting for 29% (17/59) of
deaths within 1 year. Over half (55%, 17/31) of the patients
who had severe, surgery-related complications (anastomotic
leakage, intra-abdominal haemorrhage, ileus) diedwithin 1 year
after surgery whereas 1-year mortality was 8.6% (20/232) for
the patients without postoperative complications. In patients
with mild complications (Clavien-Dindo I–II), mortality was
9.4%. Patients with severe postoperative complications
(Clavien-Dindo III–V) had mortality 45% (31/69). (Fig. 1).
Patients with stage III disease (n = 146) and treated with
postoperative chemotherapy had lower 1-year mortality rate
compared with patients not receiving adjuvant treatment
(10.4% vs 27.8%, p = 0.007).
Univariate logistic regression analysis showed that living
in a nursing home, hospital admissions 6 months before sur-
gery, CCI score > 6, longer operation time, greater intraoper-
ative blood loss and severe postoperative complications were
significant patient-related variables affecting 30-daymortality.
Higher age, hospital admissions 6 months before surgery,
open compared with laparoscopic operation, longer operative
time, greater intraoperative blood loss and severe postopera-
tive complications were associated with greater 1-year mortal-
ity after surgery (Table 4). In multivariate logistic regression
analysis, hospital admissions 6 months before surgery and
Table 3 Postoperative
complications and
mortality
N %
Surgical complications
No 294 76.2
Yes 92 23.8
Ileus 27 7.0
Bleeding 24 6.2
Anastomotic leakage 22 5.7
Wound dehiscence 7 1.8
Wound infection 2 0.5
Others 10 2.6
Non-surgical complications
No 317 82.1
Yes 69 17.9
Cardiovascular 23 6.0
Respiratory 18 4.7
Urinary 11 2.8
Delirium 5 1.3
Other 12 3.1
30-day mortality 23 6.0
90-day mortality 29 7.5
1-year mortality 59 15.3
Table 2 Surgical characteristics and outcomes
n / med % / (range)
Procedure
Right hemicolectomy 261 67.6
Transversum resection 6 1.6
Left hemicolectomy 22 5.7
Sigmoid resection 83 21.5
Other colonic resection 14 3.6
Type of surgery
Open 134 34.7
Laparoscopy 252 65.3
Conversion 35 13.9
Operation time (min) 130 33–445
Bleeding (ml) 50 5–1000
Postoperative length of hospital stay (days) 7 1–58
Discharge destination
Home 172 45.6
Other hospital or health centre 187 49.6
Death during hospital stay 18 4.8
Reoperation 39 10.1
Readmission 25 6.5
TNM stage
1 41 12.7
2 191 49.5
3 146 37.8
Number of lymph nodes 14.8 3–71
Fig. 1 Kaplan-Meier analysis of 1-year overall survival in electively
operated colon cancer patients > 80 years of age with and without
complications according to Clavien-Dindo classification (p < 0.001,
log-rank)
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severe postoperative complications were the only significant
patient-related variables affecting 30-day mortality (OR 3.05,
95% CI 1.25–7.43, p = 0.014 and OR 85.61, 95% CI 10.68–
686.1, p < 0.001). Severe postoperative complications were
Table 4 Predictors of 30-day and 1-year mortality in elective colon cancer surgery in the aged (univariate analysis)
30-day mortality 1-year mortality
OR 95% CI p value OR 95% CI p value
Age 1.11 0.99–1.24 0.079 1.12 1.04–1.21 0.004
Gender
Female 1 1
Male 2.09 0.88–4.95 0.095 1.10 0.63–1.92 0.739
BMI (kg/m2) 0.94 0.96
< 25 1 1
25–29.9 1.19 0.45–3.11 0.725 0.95 0.49–1.85 0.887
>=30 0.34 0.04–2.73 0.310 0.64 0.23–1.78 0.395
Type of living
Home 1 1
Nursing home 3.63 1.34–9.88 0.012 1.93 0.86–4.34 0.112
Hospital admissions < 6 months
No 1 1
One or more 3.97 1.68–9.38 0.002 1.88 1.04–3.38 0.035
ASA
2 1 1
3 0.88 0.19–4.09 0.875 1.86 0.54–6.36 0.324
4 1.86 0.38–9.23 0.447 3.14 0.86–11.5 0.083
CCI score (4–15)
4 1 1
5 2.57 0.51–13.0 0.254 1.15 0.55–2.42 0.710
6 5.0 1.01–24.7 0.049 1.05 0,45–2.45 0.910
7–15 7.64 1.57–37.2 0.012 2.08 0.93–4.65 0.075
Stage
1–2 1 1
3 0.87 0.36–2.11 0.757 1.74 0.99–3.03 0.053
Type of surgery
Laparoscopy/conversion 1 1
Open 1.79 0.67–4.17 0.178 1.88 1.08–3.30 0.027
Operation time (min) 1.01 1.00–1.01 0.038 1.01 1.00–1.01 0.010
Blood loss (10 ml) n = 197 1.03 1.01–1.05 0.005 1.03 1.01–1.05 0.001
Clavien-Dindo classification
No 1 1
I–II 2.75 0.17–44.46 0.480 1.10 0.47–2.60 0.830
III–V 101.06 13.3–769.5 < 0.001 8.65 4.47–16.73 < 0.001
Complications
No 1 1
Surgical 25.05 3.13–200.7 0.002 2.76 1.40–5.46 0.004
Non-surgical 61.29 7.83–479.5 < 0.001 5.05 2.50–10.20 < 0.001
Operation year
2005–2008 1 1
2009–2012 0.73 0.26–2.00 0.536 0.62 0.32–1.21 0.161
2013–2016 0.66 0.23–1.88 0.436 0.54 0.27–1.08 0.082
Italic entries were statistically significant
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the only significant patient-related variable affecting 1-year
mortality (OR 9.60, 95% CI 2.33–39.55, p = 0.002).
Mortality rates in 30 days seemed to decrease between
operation years 2005–2008 (7.5%), 2009–2012 (5.6%) and
2013–2016 (5.1%). The corresponding numbers in 1 year
were 21% (2005–2008), 14% (2009–2012) and 12% (2013–
2016). For severe complications (CD III–V), the 30-day mor-
tality rates were 2005–2008 (30.8%), 2009–2012 (35%) and
2013–2016 (26.1%). The corresponding numbers in 1 year
were 50% (2005–2008), 45% (2009–2012) and 39% (2013–
2016). There was no statistically significant difference be-
tween time-trends and mortality.
Table 4 shows predictors for 30-day and 1-year mortality in
univariate analysis (binary logistic regression).
Discussion
For this retrospective population-based, cohort study, short-
term morbidity and mortality differences were analyzed in
the electively operative non-metastatic colon cancer patients
aged 80 years and over in a large, regionally representable
materials. To our knowledge, our material consisting of 386
patients is the largest dataset regarding elective colon cancer
surgery with curative intent and focusing on both postopera-
tive complications and short-term mortality in this age group.
Most of the similar studies featured surgical patients with co-
lorectal cancers [6, 8, 14, 28]. Patients undergoing resection for
rectal cancer have more personalized, multimodal treatment
options and a greater number of severe complications such as
anastomotic leakage compared with colon cancer surgery [29].
Thus, the patient data in our study was more homogenous fo-
cusing only on colon surgery. Furthermore, in Finland, treat-
ment of colorectal cancer is based on national EBM guidelines
[30]. The study hospitals also had standardized protocols for
colon cancer treatments, and the patients’ baselines as well as
operative outcomes and tumour characteristics were similar.
For non-metastatic colorectal cancer patients, surgical resec-
tion is the best option for curative treatment [3, 4]. A recent
multinational study showed that patients over 80 years have 30-
day and 1-year mortality rates of 5.5–11.4% and 17.1–23.6%,
respectively [16]. In the present study, 1-year survival rate was
91.4% for the patients without postoperative complications, and
the overall 1-year mortality was 15.3%. Most of the older pa-
tients do as well as younger patients after elective surgery and
have acceptable survival numbers. For example, recent data
from Netherlands showed similar 1-year overall survival rates
for patients under and over 75 years [18]. However, 30-day
mortality rate remains high among the oldest, and it continues
to increase well beyond the initial postoperative month causing
excess 1-year mortality. Previous studies show that major post-
operative complications are related to higher mortality rates and
are among the strongest risk factors for reduced survival in the
aged [28, 31]. Our data showed similar postoperative morbidity
and survival numbers reflecting the results of previous studies
considering excess mortality beyond initial postoperative
month [8, 13]. In our study, 1-year mortality rate of patients
with major postoperative complications was 44.9%, this being
the most important factor for diminished short-term survival
after colon surgery.
Our study indicated high morbidity rates in early postoper-
ative period. Almost 40% (153/386) of the patients developed
postoperative complications, and 45% (69/153) of these were
major complications. These figures are comparable with other
studies of colorectal cancer surgery reporting total complica-
tion rates 35–45% and major complications 20–25%, respec-
tively [14–17, 31]. Our data included all patients who were
willing and fit enough for surgery according to ASA classifi-
cation and other comorbidities. Risk factors for complications
were male gender, diabetes, coronary artery and rheumatic
diseases. Severe complications were more common in patients
who had increased preoperative hospitalizations and who
lived in nursing homes. These findings support recent studies
from Norway and Japan [32, 33] emphasizing the importance
of preoperative evaluation of patient’s physical and cognitive
performance, to prevent complications in colon cancer sur-
gery. In Finland, aged people move to nursing homes when
they cannot survive with maximal help at home and most of
them have some degree of cognitive impairment. Therefore,
residing in a nursing home is a kind of proxy for cognitive
impairment and disability in activities of daily living.
Unfortunately, the diagnoses for hospitalizations before sur-
gery were not documented accurately in our study data, and
the reasons for hospitalizations were heterogenous.
Postoperative complications are associated with a dispro-
portionately high risk of 30-day and 1-year mortality in elder-
ly patients [28, 31]. In our study, the overall 30-day mortality
rate was 6.0% but increased to 30.4% in patients with severe
postoperative complications. Other factors associated with in-
creased 30-day mortality included living in a nursing home,
hospital admissions 6 months before surgery, CCI score > six,
longer operation time, greater intraoperative blood loss and
severe postoperative complications. Patients with diminished
physical and mental resources had more severe postoperative
complications leading to higher mortality rates indicating that
limited performance state of patients plays an important role in
postoperative outcome [33]. Cardiopulmonary problems and
surgery-related issues were the most important factors contrib-
uting to 1-year mortality whereas cancer-related mortality was
significantly low. This finding emphasizes the importance of
preoperative evaluation on patient’s physical and cognitive
performance with specific focus on preoperative cardiopulmo-
nary status andmedical optimization. Non-surgical, symptom-
atic treatments are worth considering when individualized
treatment decisions are made for patients with limited perfor-
mance status. On the contrary, patients with stage III disease
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treated with postoperative chemotherapy had significantly
lower 1-year mortality rate compared with those who were
not giving postoperative adjuvant treatment. That underlines
the importance of identify patients who can benefit from the
radical cancer treatments.
30-day and 1-year mortality rates decreased progressively
between operation years 2005–2008, 2009–2012 and 2013–
2016, but this was not statistically significant. During the
study period, there were no preoperative arrangements for
nutrition and physical performance status assessment, or geri-
atric assessment. Conversely, all the participating hospitals in
our study had high proportion (56%) of operations done by
laparoscopy, and enhanced recovery after surgery (ERAS)
program was gradually adopted to clinical work during the
study period. A recent meta-analysis demonstrated that lapa-
roscopic colorectal surgery has positive impact in terms of
significant decrease in postoperative morbidity and mortality
among the aged compared with open colorectal surgery [34].
ERAS is a multimodal approach that aims to optimize periop-
erative management [35]. Old patients adhered to and benefit-
ed from an ERAS program have similar postoperative out-
come advantages to their younger counterparts [36]. These
facts can partly explain the similar time-trends in morbidity
and mortality between the study years, together with develop-
ments in perioperative anaesthesia care, surgical performance
(laparoscopy, technical standardization) and oncological
treatments.
Some limitations exist in our study. First, although we were
able to categorize specific comorbidities, we found little rela-
tionship between multiple morbidities and overall survival.
This may reflect the fact that there was no information avail-
able regarding the severity of the comorbidities. Additionally,
we were unable to fully assess disability and functional as well
as cognitive performance state of patients because of impre-
cise patient files. Information about daily physical and cogni-
tive functional activity and general performance was not rou-
tinely recorded. It is likely that the conditions that lead to a
patient being considered frail are only documented in those
patients whose condition had significant negative impact on
their overall well-being. The same applies to comorbidities.
However, undervaluation of such conditions would lead to
underrate of the risks and false negative results, and hence,
the reported risks are rather underestimates than overesti-
mates. In addition, and result of the previous reasons, healthier
patients were likely selected for surgical treatment. However,
our findings suggest that surgical treatment in aged patients
diagnosed with colon cancer can lead to acceptable and sim-
ilar results compared with younger patients.
Our data indicate that postoperative morbidity following
elective colon cancer surgery is common in aged patients
and results in a significant increase in mortality, which lasts
beyond the first postoperative month. Age, comorbidities, dis-
ability and the occurrence of severe postoperative
complications were factors most strongly associated with re-
duced 30-day and 1-year survival after surgery. Although we
have demonstrated an increase in survival rates, the impact of
surgical treatment on postoperative functional outcome is not
clear. Regardless of the new achievements, there seems to be a
tendency to offer fewer surgical resections to older compared
with younger patients [37, 38]. Therefore, the information on
present-day postoperative morbidity and mortality rates of
older patients is important for shared decision-making regard-
ing surgical treatment. If aged colon cancer patients survive
the first year after surgery, they have a reasonably good long-
term survival. Older patients often give higher priority to func-
tional outcomes than to survival [39]. Further research should
therefore focus not only on further increasing postoperative
survival rates in older patients but also on quality of life and
improvement of postoperative physical functioning.
Prehabilitation programs could play a role in achieving this
goal [40, 41].
In conclusion, mortality in the present study is related to
postoperative complications. Identifying effective strategies
for both prevention and tailor-made treatments of postopera-
tive complications in colon cancer surgery in the aged could
potentially improve patient overall outcomes.
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